Abstract
Study goal Evaluate differences between PCZ serum concentrations in patients receiving the DRT versus the OS and in patients receiving higher doses than 300 mg/day of the DRT Study design • Retrospective cohort study Inclusion criteria • Adult patients at Cleveland Clinic Health System • In-patient administration of posaconazole from July 1, 2014 through December 31, 2014 Patient groups • Divided and analyzed based on dosage form and dose of PCZ Contact information: Sarah Welch, Pharm.D. 9500 Euclid Ave. HB-65 Cleveland, OH, 44195 Email: welchs@ccf.org
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
